14th Biennial Thyroid Update 2023: New Concepts in the Diagnosis and Treatment of Thyroid Disease

Friday, December 1, 2023, 7:00 AM - 4:45 PM,  Bethesda Marriott, Bethesda, MD

Registration is closed and will re-open onsite December 1, 2023 at the Bethesda Marriott, Bethesda, MD

 

 

The 14th Biennial Thyroid Update will be held as an in-person event. We are delighted to bring you updates in thyroid conditions such as hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancers. This program aims to clarify the important issues surrounding the diagnosis and management of thyroid disorders, including thyroid nodules, well-differentiated thyroid cancer, medullary thyroid cancer and anaplastic thyroid cancer. The conference will focus on new approaches which include identifying patients who are candidates for re-differentiation therapy for papillary thyroid cancer and the monitoring of select patients with papillary thyroid cancer who have not had thyroid surgery. This conference will encourage the use of a multidisciplinary approach to educate clinicians about current and controversial issues in thyroid disease and will provide an opportunity for providers to become familiar with the key elements of the updated guidelines and incorporate them into their clinical practice.

1. Evaluate and compare the available molecular tests for thyroid nodules to determine which patients require thyroid surgery and which patients can be monitored.
2. Identify the cardiovascular risks associated with subclinical thyroid disease.
3. Identify the appropriate patients for radioactive iodine therapy in thyroid cancer patients.
4. Incorporate an interdisciplinary approach to the epidemiology and management of thyroid disease and cardiovascular risk.
5. Evaluate and select agents for the treatment and redifferentiation of locally advanced or metastatic thyroid cancer refractory to radioiodine therapy.
6. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with thyroid cancer.
7. Integrate a team-based approach in the care of patients with thyroid cancer.
8. Utilize stratified risk assessment for thyroid cancer.
9. Implement American Thyroid Association Guideline for the evaluation and management of hyperthyroidism.
10. Identify proper thyroid cancer patient selection for monitoring, lobectomy, or total thyroidectomy.
11. Implement American Thyroid Association Guideline recommendations for evaluation and management of thyroid nodules and thyroid cancer.
12. Evaluate when to use tissue genotyping in the management of advanced thyroid cancer.

• Physician $275
• Resident or Fellow $150
• Physician Assistant $175
• Nurse Practitioner $175
• Nurse $175
• Pharmacist $175
• Allied Health Professional $175
• Industry Professional $325

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.  

 

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 8.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

 

Physicians: MedStar Health designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Board of Internal Medicine MOC Credit: 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

American Board of Surgery CC Credit:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

 

MOC/CC Participation Threshold: Learner participates by writing a reflective statement and makes a commitment to change or maintain an element of practice.

 

Nurses: This activity is approved for 8.25 ANCC contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists: This activity is approved for 8.25 contact hour(s).  This learning activity is knowledge-based. The Universal Activity Number for this program is UAN# JA4008151-0000-23-051-L04-P.

AMA PRA Category 1 Credits™ Physician (8.25 hours), ABIM MOC Part 2 (8.25 hours), ABS CC (8.25 hours), ABS CC SAM (8.25 hours), IPCE (8.25 hours), Non-Physician Member of the Healthcare Team (8.25 hours), Nurse - ANCC (8.25 hours), Pharmacist - ACPE (8.25 hours)

The registration form for this activity is currently unavailable.

Bethesda Marriott
5151 Pooks Hill Road
Bethesda, MD 20814
For more information regarding the hotel, please visit the Hotel Website

Friday, December 1, 2023

For information on exhibiting at this conference please contact Elizabeth Romano at [email protected]